Jazz Pharma CMO on GEA Data, Pipeline with Bloomberg Intelligence and Leerink

On Demand

Duration: 57 Minutes

Original Date: April 27, 2025

First name

Last name

Business email

Business phone

Company

Job role

Industry

City

Country or Region

State or Province Optional

Yes, I would like to be contacted by a representative to learn more about Bloomberg's solutions and services.

What are you interested in learning more about?

By submitting this information, I agree to the privacy policy and to learn more about products and services from Bloomberg.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Join Bloomberg Intelligence equity analyst Ann-Hunter van Kirk for a conversation with Robert Iannone, head of R&D and CMO of Jazz Pharmaceuticals and Leerink equity analysts Marc Goodman and Andrew Berens ahead of upcoming zanidatamab data in GEA. We'll also discuss the anticipated Zepzelca 1L ES-SCLC sNDA and more about Jazz's pipeline.

Jazz Pharma CMO on GEA Data, Pipeline with Bloomberg Intelligence and Leerink

Access a broad range of analysis, research, insight and actionable ideas with Bloomberg webinars.